The observed outcomes were facilitated through increased Nrf2 protein transport and the activation of its target genes, including heme oxygenase-1 (HO-1) and NAD(P)H quinone oxidoreductase 1 (NQO1) (74)
But because human data support the interaction, caution and monitoring are appropriate
The Dietary Supplement Health and Education Act (DSHEA) of 1994 places the burden of proof on the FDA to show a supplement is unsafe, rather than requiring the manufacturer to prove it is effective
Another transporter, CACT (carnitine-acylcarnitine translocase) is located in the inner mitochondrial membrane and contributes to the exchange of acylcarnitine and longer acylcarnitines for carnitine to ensure acetylcarnitine transfer across the inner mitochondrial membrane [90]
Currently, there is only one drug in this class of medicationstirzepatide, which is approved as Mounjaro for treatment of Type 2 diabetes and as Zepbound for the treatment of obesity
Choosing a GLP-1 program is not one-size-fits-all